Conferences . . Press Releases . . Alliances

BioVerdant will create considerable value for our partners with clinical or commercial programs where significant reductions in the manufacturing cost of the active pharmaceutical ingredients are desired. BioVerdant will utilize its expertise and technologies to provide new solutions for cost effective manufacture while generating intellectual property related to novel intermediates and manufacturing processes. Technologies developed for our partners will be transferred to the partner for manufacturing scale synthesis.

If you are interested in an alliance with BioVerdant or learning more about us please contact Sanford Madigan at 858.368.6006 or email sandy.madigan@bioverdant.com.